156 related articles for article (PubMed ID: 19961842)
1. Clinical significance of Stratifin, ERalpha and PR promoter methylation in tumor and serum DNA in Indian breast cancer patients.
Mirza S; Sharma G; Parshad R; Srivastava A; Gupta SD; Ralhan R
Clin Biochem; 2010 Mar; 43(4-5):380-6. PubMed ID: 19961842
[TBL] [Abstract][Full Text] [Related]
2. Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients.
Mirza S; Sharma G; Prasad CP; Parshad R; Srivastava A; Gupta SD; Ralhan R
Life Sci; 2007 Jul; 81(4):280-7. PubMed ID: 17599361
[TBL] [Abstract][Full Text] [Related]
3. Hypermethylated 14-3-3-sigma and ESR1 gene promoters in serum as candidate biomarkers for the diagnosis and treatment efficacy of breast cancer metastasis.
Zurita M; Lara PC; del Moral R; Torres B; Linares-Fernández JL; Arrabal SR; Martínez-Galán J; Oliver FJ; Ruiz de Almodóvar JM
BMC Cancer; 2010 May; 10():217. PubMed ID: 20487521
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of promoter hypermethylation of ERβ and RARβ2 in tumor and serum DNA in Indian breast cancer patients.
Mirza S; Sharma G; Parshad R; Srivastava A; Gupta SD; Ralhan R
Ann Surg Oncol; 2012 Sep; 19(9):3107-15. PubMed ID: 22451234
[TBL] [Abstract][Full Text] [Related]
5. CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis.
Ramezani F; Salami S; Omrani MD; Maleki D
Asian Pac J Cancer Prev; 2012; 13(2):451-7. PubMed ID: 22524805
[TBL] [Abstract][Full Text] [Related]
6. Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast.
Asiaf A; Ahmad ST; Malik AA; Aziz SA; Rasool Z; Masood A; Zargar MA
Tumour Biol; 2015 Aug; 36(8):6485-96. PubMed ID: 25820821
[TBL] [Abstract][Full Text] [Related]
7. Quantitative detection of methylated ESR1 and 14-3-3-sigma gene promoters in serum as candidate biomarkers for diagnosis of breast cancer and evaluation of treatment efficacy.
Martínez-Galán J; Torres B; Del Moral R; Muñoz-Gámez JA; Martín-Oliva D; Villalobos M; Núñez MI; Luna Jde D; Oliver FJ; Ruiz de Almodóvar JM
Cancer Biol Ther; 2008 Jun; 7(6):958-65. PubMed ID: 18379196
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.
Sharma G; Mirza S; Parshad R; Srivastava A; Gupta SD; Pandya P; Ralhan R
Life Sci; 2010 Jul; 87(3-4):83-91. PubMed ID: 20470789
[TBL] [Abstract][Full Text] [Related]
9. Aberrant stratifin overexpression is regulated by tumor-associated CpG demethylation in lung adenocarcinoma.
Shiba-Ishii A; Noguchi M
Am J Pathol; 2012 Apr; 180(4):1653-62. PubMed ID: 22310466
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation of circulating DNA: a marker for monitoring efficacy of neoadjuvant chemotherapy in breast cancer patients.
Sharma G; Mirza S; Parshad R; Gupta SD; Ralhan R
Tumour Biol; 2012 Dec; 33(6):1837-43. PubMed ID: 22744714
[TBL] [Abstract][Full Text] [Related]
11. DNA hypermethylation of ESR1 and PGR in breast cancer: pathologic and epidemiologic associations.
Gaudet MM; Campan M; Figueroa JD; Yang XR; Lissowska J; Peplonska B; Brinton LA; Rimm DL; Laird PW; Garcia-Closas M; Sherman ME
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3036-43. PubMed ID: 19861523
[TBL] [Abstract][Full Text] [Related]
12. Association of poor prognosis subtypes of breast cancer with estrogen receptor alpha methylation in Iranian women.
Izadi P; Mehrdad N; Foruzandeh F; Reza NM
Asian Pac J Cancer Prev; 2012; 13(8):4113-7. PubMed ID: 23098526
[TBL] [Abstract][Full Text] [Related]
13. CpG hypomethylation of MDR1 gene in tumor and serum of invasive ductal breast carcinoma patients.
Sharma G; Mirza S; Parshad R; Srivastava A; Datta Gupta S; Pandya P; Ralhan R
Clin Biochem; 2010 Mar; 43(4-5):373-9. PubMed ID: 19879256
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor alpha (ERα) promoter methylation status in tumor and serum DNA in Egyptian breast cancer patients.
Hagrass HA; Pasha HF; Ali AM
Gene; 2014 Nov; 552(1):81-6. PubMed ID: 25218234
[TBL] [Abstract][Full Text] [Related]
15. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.
Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G
FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091
[TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
Kunze E; Wendt M; Schlott T
Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of Maspin promoter methylation and loss of its protein expression in invasive ductal breast carcinoma: correlation with VEGF-A and MTA1 expression.
Sharma G; Mirza S; Parshad R; Srivastava A; Gupta SD; Pandya P; Ralhan R
Tumour Biol; 2011 Feb; 32(1):23-32. PubMed ID: 20697987
[TBL] [Abstract][Full Text] [Related]
18. Loss of expression and aberrant methylation of the CDH1 (E-cadherin) gene in breast cancer patients from Kashmir.
Asiaf A; Ahmad ST; Aziz SA; Malik AA; Rasool Z; Masood A; Zargar MA
Asian Pac J Cancer Prev; 2014; 15(15):6397-403. PubMed ID: 25124632
[TBL] [Abstract][Full Text] [Related]
19. Detection of RASSF1A and RARbeta hypermethylation in serum DNA from breast cancer patients.
Shukla S; Mirza S; Sharma G; Parshad R; Gupta SD; Ralhan R
Epigenetics; 2006; 1(2):88-93. PubMed ID: 17998817
[TBL] [Abstract][Full Text] [Related]
20. Prognostic relevance of promoter hypermethylation of multiple genes in breast cancer patients.
Sharma G; Mirza S; Yang YH; Parshad R; Hazrah P; Datta Gupta S; Ralhan R
Cell Oncol; 2009; 31(6):487-500. PubMed ID: 19940364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
